The binding may alter the downstream metabolic function of the receptors by upregulating certain gene signatures such as MAPK, TP63, ERK, PTEN, AKT1, and NfKB1, which are key transcription factors and kinases implicated in T2DM prognosis and pathogenesis. The gene discussed is TP63; the disease is type 2 diabetes mellitus.